The North-American rat model market was worth $XX thousand in the year 2018. It is growing at a CAGR of 8.14% for the forecast period 201-2027 and is expected to be worth $XX thousand by the year 2027. The market is expected to hold the largest share by the end of the forecast period because of the major driving factors like enhanced techniques for genome editing, growing research and developments by biotechnological and biopharmaceutical companies and the fairly accessible rat transgenic methodologies.
NORTH AMERICA RAT MODEL MARKET FORECAST 2019- 2027
North America Rat Model Market by Rat Type (Inbred, Genetically Engineered Rats, Surgically Modified Rats, Hybrid, Outbred, Immune-deficient) by Application (Diabetes, Toxicology, Oncology, Immunology & Inflammation, Other Application) by Component(Technology, Services, Rat Care Products) by Geography.
The North-American rat model market was worth $XX thousand in the year 2018. It is growing at a CAGR of 8.14% for the forecast period 201-2027 and is expected to be worth $XX thousand by the year 2027. The market is expected to hold the largest share by the end of the forecast period because of the major driving factors like enhanced techniques for genome editing, growing research and developments by biotechnological and biopharmaceutical companies and the fairly accessible rat transgenic methodologies
The countries mainly analyzed for this region are the United States and Canada. The U.S market holds the largest share in this region due to a high requisite for rats in the pre-clinical animal trial studies by CROs and major biopharmaceutical companies. Rising demand for rat models for research related activities from emerging economies, personalized medicine established to surge the demand and an escalation in monoclonal antibody production are opening a plethora of opportunities for the rat model market. However, the high expenses involved in producing these models is proving challenging for the overall market growth.
LabCorp is one of the major players in the North American market with over xx primary laboratories in the US. Over the years, the company has taken over many leading testing and diagnostic research companies from all over the world and is now focusing mainly on genomic research. The other big companies competing in the market are Janvier Labs, Hera Biolabs Inc., Vivo Biotech Ltd., Cyagen Biosciences Inc., Envigo, Biomere, Charles River Laboratories Inc., Oncodesign S.A., Taconic Biosciences, Genoway S.A., Transviragen Inc., Clea Japan, Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Laboratory Corporation of America Holdings and Transposagen Biopharmaceuticals Inc.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
- ONCOLOGY IS THE FASTEST GROWING APPLICATION
- RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- ENHANCEMENT IN GENOME EDITING
- GROWING AVAILABILITY IN RAT TRANSGENIC
- SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
- MARKET RESTRAINTS
- UNETHICAL PRACTICE OF ANIMALS IN RESEARCH
- FLUCTUATING RULES AND REGULATION ON ANIMAL TESTING
- USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
- IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
- MARKET OPPORTUNITIES
- PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
- ESCALATION IN MONOCLONAL ANTIBODY CREATION
- MARKET CHALLENGES
- HIGHLY EXPENSIVE RAT MODEL
- MARKET BY RAT TYPE
- INBRED
- GENETICALLY ENGINEERED RATS
- SURGICALLY MODIFIED RATS
- HYBRID
- OUTBRED
- IMMUNE-DEFICIENT
- MARKET BY APPLICATION
- DIABETES
- TOXICOLOGY
- ONCOLOGY
- IMMUNOLOGY & INFLAMMATION
- OTHER APPLICATION
- MARKET BY COMPONENT
- TECHNOLOGY
- NUCLEAR TRANSFERASE
- MICROINJECTION
- EMBRYONIC STEM CELL INJECTION
- OTHER TECHNOLOGY
- SERVICES
- RAT CARE PRODUCTS
- FEED
- BEDDING
- CAGES
- OTHER RAT CARE PRODUCTS
- TECHNOLOGY
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE PRODUCT
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- INTENSITY OF COMPETITIVE RIVALRY
- VALUE CHAIN ANALYSIS
- REGULATORY FRAMEWORK
- KEY BUYING CRITERIA
- HIGH ACCURACY
- HIGH EFFICACY
- QUALITY OF OPERATING PROCEDURE
- PRICE
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- BIOMERE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- CHARLES RIVER LABORATORIES INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CLEA JAPAN
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- CYAGEN BIOSCIENCES INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- ENVIGO
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- GENOWAY S. A.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- HERA BIOLABS INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- JANVIER LABS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRATEGIC INITIATIVES
- ONCODESIGN S.A.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TACONIC BIOSCIENCES
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TRANSPOSAGEN BIOPHARMACEUTICALS INC
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- TRANSVIRAGEN INC.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- VIVO BIOTECH LTD.
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- BIOMERE
TABLE LIST
TABLE 1Â Â Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET 2019-2027 ($ MILLION)
TABLE 2Â Â Â Â Â Â Â BENEFITS OF RAT TRANSGENIC
TABLE 3Â Â Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
TABLE 4Â Â Â Â Â Â Â EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
TABLE 5Â Â Â Â Â Â Â NORTH AMERICA INBRED MARKET 2019-2027 ($ MILLION)
TABLE 6Â Â Â Â Â Â Â NORTH AMERICA GENETICALLY ENGINEERED RATS MARKET 2019-2027 ($ MILLION)
TABLE 7Â Â Â Â Â Â Â NORTH AMERICA SURGICALLY MODIFIED RATS MARKET 2019-2027 ($ MILLION)
TABLE 8Â Â Â Â Â Â Â NORTH AMERICA HYBRID MARKET 2019-2027 ($ MILLION)
TABLE 9Â Â Â Â Â Â Â NORTH AMERICA OUTBRED MARKET 2019-2027 ($ MILLION)
TABLE 10Â Â Â Â Â NORTH AMERICA IMMUNE-DEFICIENT MARKET 2019-2027 ($ MILLION)
TABLE 11Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 12Â Â Â Â Â NORTH AMERICA DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 13Â Â Â Â Â NORTH AMERICA TOXICOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 14Â Â Â Â Â NORTH AMERICA ONCOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 15Â Â Â Â Â NORTH AMERICA IMMUNOLOGY & INFLAMMATION MARKET 2019-2027 ($ MILLION)
TABLE 16Â Â Â Â Â NORTH AMERICA OTHER APPLICATION MARKET 2019-2027 ($ MILLION)
TABLE 17Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
TABLE 18Â Â Â Â Â NORTH AMERICA TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 19Â Â Â Â Â NORTH AMERICA NUCLEAR TRANSFERASE MARKET 2019-2027 ($ MILLION)
TABLE 20Â Â Â Â Â NORTH AMERICA MICRO INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 21Â Â Â Â Â NORTH AMERICA EMBRYONIC STEM CELL INJECTION MARKET 2019-2027 ($ MILLION)
TABLE 22Â Â Â Â Â NORTH AMERICA OTHER TECHNOLOGY MARKET 2019-2027 ($ MILLION)
TABLE 23Â Â Â Â Â NORTH AMERICA SERVICES MARKET 2019-2027 ($ MILLION)
TABLE 24Â Â Â Â Â NORTH AMERICA RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 25Â Â Â Â Â NORTH AMERICA FEED MARKET 2019-2027 ($ MILLION)
TABLE 26Â Â Â Â Â POPULAR FOOD FOR RATS
TABLE 27Â Â Â Â Â NORTH AMERICA BEDDING MARKET 2019-2027 ($ MILLION)
TABLE 28Â Â Â Â Â NORTH AMERICA CAGES MARKET 2019-2027 ($ MILLION)
TABLE 29Â Â Â Â Â NORTH AMERICA OTHER RAT CARE PRODUCTS MARKET 2019-2027 ($ MILLION)
TABLE 30Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 31Â Â Â Â Â RAT MODEL COMPANY POSITION ANALYSIS
FIGURES LISTÂ Â Â Â Â Â
FIGURE 1Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 2Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
FIGURE 3Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
FIGURE 4Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
FIGURE 5Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
FIGURE 6Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
FIGURE 7Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
FIGURE 8Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
FIGURE 9Â Â Â Â Â NORTH AMERICA RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 10Â Â PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 & 2040
FIGURE 11Â Â NORTH AMERICA RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 12Â Â NORTH AMERICA RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
FIGURE 13Â Â NORTH AMERICA RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
FIGURE 14Â Â NORTH AMERICA RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
FIGURE 15Â Â NORTH AMERICA RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
FIGURE 16Â Â NORTH AMERICA RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
FIGURE 17Â Â NORTH AMERICA RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 18Â Â NORTH AMERICA RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
FIGURE 19Â Â NORTH AMERICA RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
FIGURE 20Â Â NORTH AMERICA RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
FIGURE 21Â Â NORTH AMERICA RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
FIGURE 22Â Â NORTH AMERICA RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
FIGURE 23Â Â NORTH AMERICA RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 24Â Â NORTH AMERICA RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
FIGURE 25Â Â NORTH AMERICA RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
FIGURE 26Â Â NORTH AMERICA RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
FIGURE 27Â Â NORTH AMERICA RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
FIGURE 28  PORTER’S FIVE FORCE MODEL
FIGURE 29Â Â THE UNITED STATES RAT MODEL MARKET 2019-2027 ($ MILLION)
FIGURE 30Â Â NATIONAL HUMAN GENOME RESEARCH BUDGET 2017 ($ MILLION)
FIGURE 31Â Â CANADA RAT MODEL MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY RAT TYPE
- INBRED
- GENETICALLY ENGINEERED RATS
- SURGICALLY MODIFIED RATS
- HYBRID
- OUTBRED
- IMMUNE-DEFICIENT
- MARKET BY APPLICATION
- DIABETES
- TOXICOLOGY
- ONCOLOGY
- IMMUNOLOGY & INFLAMMATION
- OTHER APPLICATION
- MARKET BY COMPONENT
- TECHNOLOGY
- NUCLEAR TRANSFERASE
- MICROINJECTION
- EMBRYONIC STEM CELL INJECTION
- OTHER TECHNOLOGY
- SERVICES
- RAT CARE PRODUCTS
- FEED
- BEDDING
- CAGES
- OTHER RAT CARE PRODUCTS
- TECHNOLOGY
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
Choose License Type
RELATED REPORTS
-
NORTH AMERICA MOBILE IMAGING SERVICES MARKET FORECAST 2025-2032
-
NORTH AMERICA HYALURONIC ACID MARKET FORECAST 2025-2032
-
NORTH AMERICA COLLAGEN MARKET FORECAST 2025-2032
-
NORTH AMERICA ATV AND UTV MARKET FORECAST 2025-2032
-
NORTH AMERICA GAMING MARKET FORECAST 2025-2032
-
NORTH AMERICA ORTHOGNATHIC CRANIOMAXILLOFACIAL (CMF) DEVICES MARKET FORECAST 2025-2032
-
GLOBAL HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
ASIA-PACIFIC HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
EUROPE HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032
-
NORTH AMERICA HALAL PHARMACEUTICALS MARKET FORECAST 2025-2032